109 related articles for article (PubMed ID: 8602984)
41. Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product.
Dreger P; Marquardt P; Haferlach T; Jacobs S; Mülverstedt T; Eckstein V; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
Br J Cancer; 1993 Nov; 68(5):950-7. PubMed ID: 7692921
[TBL] [Abstract][Full Text] [Related]
42. [Autologous transplantation of hematopoietic precursor cells following CD34 selection].
Tichelli A; Gratwohl A; Bargetzi M; Nissen C; Wernli M; Herrmann R; Orth B; Signer E; Speck B
Schweiz Med Wochenschr; 1996 Feb; 126(6):201-6. PubMed ID: 8720723
[TBL] [Abstract][Full Text] [Related]
43. Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
Bensinger W; Appelbaum F; Rowley S; Storb R; Sanders J; Lilleby K; Gooley T; Demirer T; Schiffman K; Weaver C
J Clin Oncol; 1995 Oct; 13(10):2547-55. PubMed ID: 7595706
[TBL] [Abstract][Full Text] [Related]
44. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
45. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
46. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
Abonour R; Scott KM; Kunkel LA; Robertson MJ; Hromas R; Graves V; Lazaridis EN; Cripe L; Gharpure V; Traycoff CM; Mills B; Srour EF; Cornetta K
Bone Marrow Transplant; 1998 Nov; 22(10):957-63. PubMed ID: 9849692
[TBL] [Abstract][Full Text] [Related]
47. Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels.
Dobo I; Pineau D; Robillard N; Geneviève F; Piard N; Zandecki M; Hermouet S
J Hematother Stem Cell Res; 2003 Oct; 12(5):543-51. PubMed ID: 14594511
[TBL] [Abstract][Full Text] [Related]
48. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
[TBL] [Abstract][Full Text] [Related]
49. Peripheral blood progenitor cell harvesting in multiple myeloma and malignant lymphoma.
Scott MA; Ager S; Apperley JF; Jestice HK; Bloxham DM; Boraks P; Mahendra P; Marcus RE
Leuk Lymphoma; 1995 Nov; 19(5-6):479-84. PubMed ID: 8590850
[TBL] [Abstract][Full Text] [Related]
50. Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application.
Comenzo RL; Michelle D; LeBlanc M; Wally J; Zhang Y; Kica G; Karandish S; Arkin CF; Wright DG; Skinner M; McMannis J
Transfusion; 1998 Jan; 38(1):60-9. PubMed ID: 9482396
[TBL] [Abstract][Full Text] [Related]
51. Changes in reticulocyte fractions during peripheral stem cell harvesting: role in monitoring stem cell collection.
Remacha AF; Martino R; Sureda A; Sarda MP; Solá C; Tugues D; Amill B; Garcia J; Oliver A
Bone Marrow Transplant; 1996 Feb; 17(2):163-8. PubMed ID: 8640161
[TBL] [Abstract][Full Text] [Related]
52. Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's Lymphoma?
Dazzi C; Cariello A; Rosti G; Argnani M; Sebastiani L; Ferrari E; Zornetta L; Monti G; Nicoletti P; Baioni M; Salvucci M; Scarpi E; Marangolo M
Leuk Lymphoma; 2000 Oct; 39(3-4):301-10. PubMed ID: 11342310
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSC(lo) ALDH(br) cells on hematopoietic recovery.
Gündüz E; Demirel G; Bal C; Gulbas Z
Cytotherapy; 2010 Dec; 12(8):1006-12. PubMed ID: 20735165
[TBL] [Abstract][Full Text] [Related]
54. Hematopoietic potential and retroviral transduction of CD34+ Thy-1+ peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1-infected individuals mobilized with granulocyte colony-stimulating factor.
Junker U; Moon JJ; Kalfoglou CS; Sniecinski I; Forman SJ; Zaia JA; Kaneshima H; Böhnlein E
Blood; 1997 Jun; 89(12):4299-306. PubMed ID: 9192752
[TBL] [Abstract][Full Text] [Related]
55. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
Ho AD; Young D; Maruyama M; Corringham RE; Mason JR; Thompson P; Grenier K; Law P; Terstappen LW; Lane T
Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228
[TBL] [Abstract][Full Text] [Related]
56. Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses.
Dobo I; Robillard N; Pineau D; Geneviève F; Piard N; Rapp MJ; Boasson M; Zandecki M; Hermouet S
Ann Hematol; 2001 Nov; 80(11):639-46. PubMed ID: 11757722
[TBL] [Abstract][Full Text] [Related]
57. Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.
Lefrere F; Makke J; Fermand J; Marolleau J; Dal Cortivo L; Alberti C; Mouton V; Benbunan M; Miclea J
Bone Marrow Transplant; 1999 Sep; 24(5):463-6. PubMed ID: 10482928
[TBL] [Abstract][Full Text] [Related]
58. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
[TBL] [Abstract][Full Text] [Related]
59. CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome.
Gupta D; Bybee A; Cooke F; Giles C; Davis JG; McDonald C; Armitage SE; McGuigan D; Lyttelton MP; Kanfer EJ; Apperley JF; Samson D
Br J Haematol; 1999 Jan; 104(1):166-77. PubMed ID: 10027730
[TBL] [Abstract][Full Text] [Related]
60. Kinetics of hemopoietic recovery after peripheral blood stem cell transplantation: impact of stem cell purification and G-CSF.
Piccirillo N; Sorà F; Laurenti L; Chiusolo P; Serafini R; Cicconi S; Leone G; Sica S
Am J Hematol; 2002 Jan; 69(1):7-14. PubMed ID: 11835324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
